← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2015Last known activity
Jan 6, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT06525389CollaboratorPhase 3Jan 6, 2025
- NCT05082727Overall official - principal investigatorPhase 2Jul 1, 2021
- NCT04521036CollaboratorPhase 1/Phase 2Dec 1, 2020
- NCT04516954CollaboratorEarly Phase 1Aug 1, 2020
- NCT04328493CollaboratorPhase 2Apr 1, 2020
- NCT02334670Lead sponsorN/AMay 1, 2015
Details
- Last known activity
- Jan 6, 2025